Christopher A. Viehbacher Joins Pronutria Biosciences’ Board of Directors

Pronutria Biosciences Inc., a biotechnology company pioneering a new therapeutic modality to mediate amino acid biology, today announced that Christopher A. Viehbacher, Managing Partner, Gurnet Point Capital, will join Pronutria’s Board of Directors, according to a Business Wire press release.In addition, Gurnet Point Capital has made an investment in Pronutria, the fund’s first announced investment, completing Pronutria's Series C financing. The terms of the investment were not disclosed.Read the full press release here.